Dexlansoprazol
RxNorm 816346· ATC A02BC06· dexlansoprazole
KR · 한국Produtos na Coreia (10)
- 덱시라졸캡슐60밀리그램(덱스란소프라졸)(주)유한양행
- 덱시라졸캡슐60밀리그램(덱스란소프라졸)(주)유한양행
- 덱시라졸캡슐30밀리그램(덱스란소프라졸)(주)유한양행
- 덱시라졸캡슐30밀리그램(덱스란소프라졸)(주)유한양행
- 덱실란트디알캡슐30밀리그램(덱스란소프라졸)한국다케다제약(주)
- 덱실란트디알캡슐30밀리그램(덱스란소프라졸)한국다케다제약(주)
- 덱실란트디알캡슐30밀리그램(덱스란소프라졸)한국다케다제약(주)
- 덱실란트디알캡슐60밀리그램(덱스란소프라졸)한국다케다제약(주)
- 덱실란트디알캡슐60밀리그램(덱스란소프라졸)한국다케다제약(주)
- 덱실란트디알캡슐60밀리그램(덱스란소프라졸)한국다케다제약(주)
U.S. drug label (openFDA)
Dexlansoprazole delayed release — indications, dosage, warnings, adverse events →Química (PubChem)
- Fórmula molecular
- C16H14F3N3O2S
- Massa molecular
- 369.4 g/mol
- Nome IUPAC
- 2-[(R)-[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methylsulfinyl]-1H-benzimidazole
- InChIKey
- MJIHNNLFOKEZEW-RUZDIDTESA-N